BBIO
Conviction 39HealthcareScan · Thu, Sep 24, 2026BridgeBio Pharma, Inc. (BBIO) closed at $66.23 (+0.79%) on Sep 24, 2026. Its latest daily candle is a bullish harami. Price is below its 50-day and below its 200-day moving average. RSI(14) 29, RS Rating 79, -26.6% from its 52-week high, -15.3% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.
Financials as of Sun, Jun 30, 2019 · quarterly.
Recent news
- BridgeBio Pharma stock finds support near USD 66AD HOC NEWS · Wed, Sep 23, 2026
- BridgeBio Pharma CEO Neil Kumar sells $690,847 in shares By Investing.comInvesting.com Nigeria · Mon, Sep 21, 2026
- BridgeBio (NASDAQ: BBIO) CEO’s trust sells 10,000 shares under preset planStock Titan · Mon, Sep 21, 2026
- 7 Red Days In A Row: BridgeBio Pharma Stock Is Down 12%Trefis · Mon, Sep 21, 2026
- BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Navigating a 63.78% Potential Upside in the Biotech SectorDirectorsTalk Interviews · Mon, Sep 21, 2026
Congress activity
Disclosed STOCK Act trades in BBIO · 4 recent
| Member | Side | Amount | Traded | Filed | PTR |
|---|---|---|---|---|---|
Gilbert Cisneros house · CA · traded 2026-05-11 | Buy | $1K–$15K | 2026-05-11 | 2026-06-05 | |
Gilbert Cisneros house · CA · traded 2026-03-19 | Buy | $1K–$15K | 2026-03-19 | 2026-04-06 | |
Gilbert Cisneros house · D · CA · traded 2025-09-22 | Buy | $1K–$15K | 2025-09-22 | 2025-10-10 | |
Gilbert Cisneros house · D · CA · traded 2025-08-08 | Buy | $1K–$15K | 2025-08-08 | 2025-09-12 |
Insider activity
SEC Form 4 transactions in BBIO · open-market 9 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kumar Neil Chief Executive Officer · Common Stock · 2026-09-17 | Sell | 8.72K | $602K | 2026-09-17 | 2026-09-21 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-09-17 | Sell | 1.28K | $89K | 2026-09-17 | 2026-09-21 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-19 | Sell | 100 | $9K | 2026-08-19 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-19 | Sell | 8.1K | $679K | 2026-08-19 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-19 | Sell | 1.8K | $152K | 2026-08-19 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-18 | Sell | 1.2K | $100K | 2026-08-18 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-18 | Sell | 14.6K | $1.2M | 2026-08-18 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-18 | Sell | 17.28K | $1.4M | 2026-08-18 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Common Stock · 2026-08-18 | Sell | 1.9K | $154K | 2026-08-18 | 2026-08-20 |
Kumar Neil Chief Executive Officer · Restricted Stock Units · 2026-08-16 | Exercise | 11.55K | — | 2026-08-16 | 2026-08-18 |
SEC filings
EDGAR filings in BBIO · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.